PRotect after depression: a randomised pilot trial

  • Research type

    Research Study

  • Full title

    PRotect after depression: a randomised pilot trial of a novel low-intensity intervention

  • IRAS ID

    166108

  • Contact name

    Stephen Pilling

  • Contact email

    s.pilling@ucl.ac.uk

  • Sponsor organisation

    UCL

  • ISRCTN Number

    ISRCTN17371456

  • Clinicaltrials.gov Identifier

    Z6364106/2016/02/05 , UCL Data Protection Registration

  • Duration of Study in the UK

    0 years, 9 months, 0 days

  • Research summary

    Does the ‘PRotect’ intervention help people to stay well after recovering from depression? \n\nDepression is a common and debilitating mental health problem. During an episode, people may suffer from low or irritable mood, loss of interest in normal activities, diminished concentration, and feelings of worthlessness and guilt. Even after recovery, people who have been depressed are at risk of experiencing a relapse. A recent systematic review concluded that psychological interventions delivered when a person is well can reduce this risk (Clarke et al, 2015). \n\nIn the UK, a large number of psychological interventions are delivered through IAPT (Improving Access to Psychological Therapies) services. There is a move within these services to expand and improve relapse prevention work following treatment of depression, but this is difficult given that existing interventions are too intensive to be routinely delivered. In view of this, we have designed the ‘PRotect’ after depression intervention. It is centred on a neurocognitive model of depressive relapse, and brings together evidence based relapse prevention strategies with behaviour change theory into a ’guided self-help’ format commonly used in IAPT. \n\nThis trial will be the first to test the ‘PRotect’ intervention. We will recruit participants who have received treatment for depression within IAPT services in Camden and Islington, and then randomly assign them to either receive the new intervention, or to be monitored. We will assess all participants after 3 and 6 months, to see if the intervention seems to have an effect on health and psychosocial functioning. We will also interview patients and clinicians about their experience of the intervention to get an understanding of whether it was useful and how it could be improved. If effective, this intervention could be routinely offered after acute treatment, and may improve wellbeing, prevent further suffering, and prevent re-presentations to healthcare services. \n

  • REC name

    London - Camden & Kings Cross Research Ethics Committee

  • REC reference

    16/LO/0652

  • Date of REC Opinion

    14 Jun 2016

  • REC opinion

    Further Information Favourable Opinion